Lotus Pharmaceuticals, Inc. (LTUS)

Lotus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Apr 24, 2025	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Market Capitalization	14	69	59	8	45	103
Market Cap Growth	-79.20%	16.98%	596.40%	-81.26%	-56.10%	-
Enterprise Value	-	74	67	16	44	111
Last Close Price	0.01	2.59	2.56	0.40	2.18	5.00
PE Ratio	0.08	4.79	3.60	0.66	4.04	24.91
PS Ratio	0.20	0.95	1.05	0.12	0.80	2.85
PB Ratio	0.14	0.78	0.90	0.19	1.70	8.74
P/TBV Ratio	0.18	1.01	3.72	0.20	1.79	9.86
P/FCF Ratio	-	-	2.92	0.24	-	21.35
P/OCF Ratio	0.76	2.58	1.89	0.23	-	21.35
EV/Sales Ratio	-	1.02	1.19	0.22	0.78	3.07
EV/EBITDA Ratio	-	3.15	3.10	1.05	3.74	21.97
EV/EBIT Ratio	-	3.48	3.41	1.09	3.93	24.83
EV/FCF Ratio	-	-	3.32	0.46	-	22.96
Debt / Equity Ratio	0.06	0.07	0.15	0.19	0.30	0.55
Debt / EBITDA Ratio	0.60	0.25	0.46	0.55	0.68	1.29
Debt / FCF Ratio	-	-	0.49	0.24	-	1.35
Asset Turnover	0.64	0.78	0.76	1.47	1.94	-
Inventory Turnover	37.27	39.32	10.38	11.29	10.29	-
Quick Ratio	0.43	0.41	0.45	1.05	5.22	2.16
Current Ratio	0.53	0.56	0.61	1.53	6.15	2.94
Return on Equity (ROE)	1.82%	18.63%	29.63%	35.64%	58.36%	-
Return on Assets (ROA)	4.56%	14.19%	16.63%	18.72%	24.11%	-
Return on Capital (ROIC)	5.04%	15.58%	19.00%	21.27%	26.65%	-
Return on Capital Employed (ROCE)	7.70%	22.40%	27.50%	27.50%	35.20%	25.70%
Earnings Yield	12.27%	20.86%	27.80%	150.69%	24.76%	4.01%
FCF Yield	-5.73%	-3.86%	34.25%	423.59%	-2.72%	4.68%
Buyback Yield / Dilution	-4.11%	-7.89%	-4.14%	-9.56%	-8.67%	-0.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.